Circulating Tumor DNA Testing Overcomes Limitations of Comprehensive Genomic Profiling from Tumor Tissue

“Liquid biopsy” is an established technique for examining circulating tumor DNA (ctDNA) from a routine blood draw and detecting actionable biomarkers. Nonetheless, ctDNA testing is rarely utilized for patients with newly diagnosed metastatic colorectal cancer (CRC). We report a case in which ctDNA t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Anivarya, Green, Michelle, Thacker, Julie, Jeck, William Richard, Strickler, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091230/
https://www.ncbi.nlm.nih.gov/pubmed/37064498
http://dx.doi.org/10.1159/000529813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091230/
https://www.ncbi.nlm.nih.gov/pubmed/37064498
http://dx.doi.org/10.1159/000529813

Ejemplares similares